EP1496764B1 - Shoe insole for diabetics - Google Patents
Shoe insole for diabetics Download PDFInfo
- Publication number
- EP1496764B1 EP1496764B1 EP03724991A EP03724991A EP1496764B1 EP 1496764 B1 EP1496764 B1 EP 1496764B1 EP 03724991 A EP03724991 A EP 03724991A EP 03724991 A EP03724991 A EP 03724991A EP 1496764 B1 EP1496764 B1 EP 1496764B1
- Authority
- EP
- European Patent Office
- Prior art keywords
- cushion
- layer
- sole
- shoe insole
- layers
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 230000007704 transition Effects 0.000 claims abstract description 10
- 210000004744 fore-foot Anatomy 0.000 claims abstract description 7
- 210000000457 tarsus Anatomy 0.000 claims abstract description 5
- 210000000452 mid-foot Anatomy 0.000 claims abstract 7
- 239000008280 blood Substances 0.000 claims abstract 2
- 210000004369 blood Anatomy 0.000 claims abstract 2
- 210000001872 metatarsal bone Anatomy 0.000 claims description 16
- 239000006260 foam Substances 0.000 claims description 3
- 210000002683 foot Anatomy 0.000 abstract description 24
- 238000007373 indentation Methods 0.000 abstract description 17
- 206010012601 diabetes mellitus Diseases 0.000 abstract description 5
- 230000002503 metabolic effect Effects 0.000 abstract description 4
- 241000131317 Capitulum Species 0.000 abstract 1
- 210000000988 bone and bone Anatomy 0.000 abstract 1
- 230000002045 lasting effect Effects 0.000 abstract 1
- 208000008960 Diabetic foot Diseases 0.000 description 4
- 239000007799 cork Substances 0.000 description 4
- 230000006872 improvement Effects 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 210000003789 metatarsus Anatomy 0.000 description 4
- RRHGJUQNOFWUDK-UHFFFAOYSA-N Isoprene Chemical compound CC(=C)C=C RRHGJUQNOFWUDK-UHFFFAOYSA-N 0.000 description 3
- 210000003423 ankle Anatomy 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 210000003205 muscle Anatomy 0.000 description 3
- 230000002093 peripheral effect Effects 0.000 description 3
- 238000002266 amputation Methods 0.000 description 2
- 230000008321 arterial blood flow Effects 0.000 description 2
- 210000001367 artery Anatomy 0.000 description 2
- 239000010985 leather Substances 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- 230000008058 pain sensation Effects 0.000 description 2
- 230000002195 synergetic effect Effects 0.000 description 2
- 239000004753 textile Substances 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 210000003371 toe Anatomy 0.000 description 2
- 210000003462 vein Anatomy 0.000 description 2
- 208000032131 Diabetic Neuropathies Diseases 0.000 description 1
- 206010054805 Macroangiopathy Diseases 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 244000309466 calf Species 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 201000002342 diabetic polyneuropathy Diseases 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000013013 elastic material Substances 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 210000004124 hock Anatomy 0.000 description 1
- 210000004324 lymphatic system Anatomy 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 206010062198 microangiopathy Diseases 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 230000004118 muscle contraction Effects 0.000 description 1
- 230000000399 orthopedic effect Effects 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 238000006213 oxygenation reaction Methods 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 239000002984 plastic foam Substances 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 230000026529 positive regulation of muscle contraction Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 208000037997 venous disease Diseases 0.000 description 1
- 210000002073 venous valve Anatomy 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A43—FOOTWEAR
- A43B—CHARACTERISTIC FEATURES OF FOOTWEAR; PARTS OF FOOTWEAR
- A43B7/00—Footwear with health or hygienic arrangements
- A43B7/14—Footwear with health or hygienic arrangements with foot-supporting parts
- A43B7/1405—Footwear with health or hygienic arrangements with foot-supporting parts with pads or holes on one or more locations, or having an anatomical or curved form
- A43B7/1415—Footwear with health or hygienic arrangements with foot-supporting parts with pads or holes on one or more locations, or having an anatomical or curved form characterised by the location under the foot
- A43B7/1425—Footwear with health or hygienic arrangements with foot-supporting parts with pads or holes on one or more locations, or having an anatomical or curved form characterised by the location under the foot situated under the ball of the foot, i.e. the joint between the first metatarsal and first phalange
-
- A—HUMAN NECESSITIES
- A43—FOOTWEAR
- A43B—CHARACTERISTIC FEATURES OF FOOTWEAR; PARTS OF FOOTWEAR
- A43B13/00—Soles; Sole-and-heel integral units
- A43B13/38—Built-in insoles joined to uppers during the manufacturing process, e.g. structural insoles; Insoles glued to shoes during the manufacturing process
- A43B13/40—Built-in insoles joined to uppers during the manufacturing process, e.g. structural insoles; Insoles glued to shoes during the manufacturing process with cushions
-
- A—HUMAN NECESSITIES
- A43—FOOTWEAR
- A43B—CHARACTERISTIC FEATURES OF FOOTWEAR; PARTS OF FOOTWEAR
- A43B17/00—Insoles for insertion, e.g. footbeds or inlays, for attachment to the shoe after the upper has been joined
-
- A—HUMAN NECESSITIES
- A43—FOOTWEAR
- A43B—CHARACTERISTIC FEATURES OF FOOTWEAR; PARTS OF FOOTWEAR
- A43B7/00—Footwear with health or hygienic arrangements
- A43B7/14—Footwear with health or hygienic arrangements with foot-supporting parts
- A43B7/1405—Footwear with health or hygienic arrangements with foot-supporting parts with pads or holes on one or more locations, or having an anatomical or curved form
- A43B7/1415—Footwear with health or hygienic arrangements with foot-supporting parts with pads or holes on one or more locations, or having an anatomical or curved form characterised by the location under the foot
- A43B7/1435—Footwear with health or hygienic arrangements with foot-supporting parts with pads or holes on one or more locations, or having an anatomical or curved form characterised by the location under the foot situated under the joint between the fifth phalange and the fifth metatarsal bone
-
- A—HUMAN NECESSITIES
- A43—FOOTWEAR
- A43B—CHARACTERISTIC FEATURES OF FOOTWEAR; PARTS OF FOOTWEAR
- A43B7/00—Footwear with health or hygienic arrangements
- A43B7/14—Footwear with health or hygienic arrangements with foot-supporting parts
- A43B7/1405—Footwear with health or hygienic arrangements with foot-supporting parts with pads or holes on one or more locations, or having an anatomical or curved form
- A43B7/1415—Footwear with health or hygienic arrangements with foot-supporting parts with pads or holes on one or more locations, or having an anatomical or curved form characterised by the location under the foot
- A43B7/144—Footwear with health or hygienic arrangements with foot-supporting parts with pads or holes on one or more locations, or having an anatomical or curved form characterised by the location under the foot situated under the heel, i.e. the calcaneus bone
-
- A—HUMAN NECESSITIES
- A43—FOOTWEAR
- A43B—CHARACTERISTIC FEATURES OF FOOTWEAR; PARTS OF FOOTWEAR
- A43B7/00—Footwear with health or hygienic arrangements
- A43B7/14—Footwear with health or hygienic arrangements with foot-supporting parts
- A43B7/1405—Footwear with health or hygienic arrangements with foot-supporting parts with pads or holes on one or more locations, or having an anatomical or curved form
- A43B7/1415—Footwear with health or hygienic arrangements with foot-supporting parts with pads or holes on one or more locations, or having an anatomical or curved form characterised by the location under the foot
- A43B7/1445—Footwear with health or hygienic arrangements with foot-supporting parts with pads or holes on one or more locations, or having an anatomical or curved form characterised by the location under the foot situated under the midfoot, i.e. the second, third or fourth metatarsal
-
- A—HUMAN NECESSITIES
- A43—FOOTWEAR
- A43B—CHARACTERISTIC FEATURES OF FOOTWEAR; PARTS OF FOOTWEAR
- A43B7/00—Footwear with health or hygienic arrangements
- A43B7/14—Footwear with health or hygienic arrangements with foot-supporting parts
- A43B7/1405—Footwear with health or hygienic arrangements with foot-supporting parts with pads or holes on one or more locations, or having an anatomical or curved form
- A43B7/1415—Footwear with health or hygienic arrangements with foot-supporting parts with pads or holes on one or more locations, or having an anatomical or curved form characterised by the location under the foot
- A43B7/145—Footwear with health or hygienic arrangements with foot-supporting parts with pads or holes on one or more locations, or having an anatomical or curved form characterised by the location under the foot situated under the toes, i.e. the phalanges
-
- A—HUMAN NECESSITIES
- A43—FOOTWEAR
- A43B—CHARACTERISTIC FEATURES OF FOOTWEAR; PARTS OF FOOTWEAR
- A43B7/00—Footwear with health or hygienic arrangements
- A43B7/14—Footwear with health or hygienic arrangements with foot-supporting parts
- A43B7/1405—Footwear with health or hygienic arrangements with foot-supporting parts with pads or holes on one or more locations, or having an anatomical or curved form
- A43B7/1455—Footwear with health or hygienic arrangements with foot-supporting parts with pads or holes on one or more locations, or having an anatomical or curved form with special properties
- A43B7/146—Footwear with health or hygienic arrangements with foot-supporting parts with pads or holes on one or more locations, or having an anatomical or curved form with special properties provided with acupressure points or means for foot massage
-
- A—HUMAN NECESSITIES
- A43—FOOTWEAR
- A43B—CHARACTERISTIC FEATURES OF FOOTWEAR; PARTS OF FOOTWEAR
- A43B7/00—Footwear with health or hygienic arrangements
- A43B7/14—Footwear with health or hygienic arrangements with foot-supporting parts
- A43B7/1405—Footwear with health or hygienic arrangements with foot-supporting parts with pads or holes on one or more locations, or having an anatomical or curved form
- A43B7/1455—Footwear with health or hygienic arrangements with foot-supporting parts with pads or holes on one or more locations, or having an anatomical or curved form with special properties
- A43B7/147—Footwear with health or hygienic arrangements with foot-supporting parts with pads or holes on one or more locations, or having an anatomical or curved form with special properties for sick or disabled persons, e.g. persons having osteoarthritis or diabetes
-
- A—HUMAN NECESSITIES
- A43—FOOTWEAR
- A43B—CHARACTERISTIC FEATURES OF FOOTWEAR; PARTS OF FOOTWEAR
- A43B7/00—Footwear with health or hygienic arrangements
- A43B7/14—Footwear with health or hygienic arrangements with foot-supporting parts
- A43B7/22—Footwear with health or hygienic arrangements with foot-supporting parts with fixed flat-foot insertions, metatarsal supports, ankle flaps or the like
Definitions
- the present invention relates to a shoe sole designed as a footbed according to the preamble of claim 1.
- a shoe insole for such persons is from the EP 0 971 606 B1 known. Such shoe insoles provide by synergistic support of muscle contraction in the movement of the ankles and hocks a significant improvement in the venous return current at the foot starting through the legs in the body.
- diabetic foot there are approximately 5 million diabetics in Germany, where a so-called "diabetic foot" can be more or less severe. This means: At the sole of the forefoot, open wounds that can become infected and that in rare cases lead to the necessity of a foot amputation (about 25,000 in Germany per year). The causes of the diabetic foot are that due to the diabetic metabolic condition in the arterial vascular system to narrow and possibly occlude larger arteries (macroangiopathy) and smaller arteries and capillaries (microangiopathy) comes. As a result, the tissue, in particular the skin, is no longer supplied with sufficient oxygen and is partially destroyed (open area).
- the skin nerves are no longer sufficiently nourished and there is diabetic polyneuropathy. This means that the affected person in the skin area, which is no longer sufficiently nourished, clearly loses the sensibility and thus the sensation of pain, so that anatomically prescribed pressure points are no longer registered and the skin is damaged "painlessly" and in this area an open skin area comes.
- Object of the present invention is therefore to provide a shoe insole of the type mentioned, which is suitable for diabetics, ie, with continued support of the arterial inflow in the foot or sole area a more positive influence on endangered by the diabetic metabolic condition foot - or soles areas brings with it.
- a particularly advantageous embodiment results from the features of claim 6 and / or in conjunction herewith from the features of claim 7 and 8, as a further support of the so-called floating state of the anatomically vulnerable sites and thus their further pressure relief is achieved.
- the shoe insole is provided as a custom-made according to the anatomically vulnerable sites found in a patient, while the features according to claim 13 relate more to a series sole preparation.
- the illustrated in the drawing and, for example, designed as a footbed shoe inner sole 11 and 111 according to two embodiments of the present invention serves in combination both the synergistic support of the muscles in the movement of the ankle and ankles to improve the arterial inflow in the foot and sole area and thus the circulation in the capillaries as well as the mechanical relief of problem areas on the soles of the feet due to (bad) diabetic metabolism. It can be designed as an insole or as a sole integrated in a shoe.
- the insole has 11 or 111 more on the sole surface 17 and 117 provided pillow-like layers 12 to 16 and 112 to 116, of which the pillow-like layers 12, 112, 13, 113 and 14, 114 in separate individual , plateau-like fields 18 to 22, 118 to 122, and 23 to 25, 123 to 125 and 26, 27, 126, 127 are divided.
- the first pillow-like layer 12, 112 is provided in the forefoot joint area, ie in the region of the toe.
- This first cushion-like layer 12, 112 is subdivided into the five fields 18 to 22, 118 to 122, which are arranged next to each other and are arranged side by side in the transverse direction of the insole 11, 111.
- the individual fields 18 to 22, 118 to 122 are of different width and length, corresponding approximately to the base area of the partial areas of the respective individual toes.
- the second pillow-like layer 13, 113 is in the transition region of the metatarsus and tarsal root and in a region which faces away from the arch of the foot , intended.
- This second pillow-like layer 13, 113 is divided into the three fields 23 to 25, 123 to 125, which are formed corresponding to this portion of metatarsus / tarsus and subdivided lying side by side in the transverse direction of the insole 11, 111.
- the third pillow-like layer 14, 114 is provided in a transition region of the metatarsus and heel and divided into the two panels 26, 126 and 27, 127, which in Transverse direction of the insole 11, 111 are seen side by side and are provided laterally outside.
- the peripheral boundary line 32, 132 corresponds approximately to the transition region from the metatarsus to the heel.
- the fourth pillow-like layer 15 or 115 is arranged in the region of the heel and is plateau-like as a unitary undivided, in the transverse or longitudinal direction of the insole 11, 111 formed approximately oval layer.
- the fifth cushion-like layer 16, 116 is formed as a uniform non-divided layer, but approximately crescent-shaped provided in the region of the arch of the foot.
- the pillow-like layers 12 to 16, 112 to 116 are made of an elastic (foam) material, for example a silicone produced. They have a flat upper surface and are approximately rectangular in cross-section, advantageously slightly trapezoidal.
- one or more indentations 61, 62, 161, 162 are provided for relieving the pressure on the head of the metatarsal .
- the indentations 61, 62 and 161, 162 are arranged in the region of the second and third metatarsal heads; it is understood that these may instead be arranged in a different number and combination in the region of the first, second, third and / or fourth metatarsal heads.
- the insole 11 has here a three-layer sole base body 36, which forms the basic shape of the insole 11 and according to FIG. 1 according to a foot, here the right foot is formed. It is understood that the corresponding other, ie left insole 11 is mirror-symmetrical.
- the sole base body 36 consists, for example, of three cork layers 33, 34, 35.
- a sole cover layer 37 is provided which, for example, is made of leather. Between the sole base body 36 and the sole cover layer 37, the pillow-like layers 12 to 16 are embedded in the sole base body 36.
- the sole base body 36 is provided in its upper and middle layer 33, 34 with corresponding recesses 38, corresponding to the fields 18 to 27 of the pillow-like layers 12 to 14 and corresponding to the pillow-like layers 15, 16 have a different base area.
- the recesses 38 are incorporated into the sole base body 36 so deep that the flat top of the plateau-like pillow-like layers 12 to 15 each in approximately one plane, ie ccplanar with the surface of the sole base body 36 is located.
- An exception is the pillow-like layer 16.
- the recesses 38 extend to the top of the lower layer 35.
- the pillow-like layers 12 to 15 each have approximately the same height and are in a range between 2 to 5 mm, preferably in one area at 3 mm.
- the upper material or the sole cover layer 37 covers the pillow-like layers 12 to 16 in such a way that these or their panels 18 to 27 are surrounded at the edge and firmly connected, preferably glued, to the middle layer 34 of the sole base body 36, so that apart from the boundary lines 28, 29 and 31, 32 approximately perpendicular to the transverse direction of the insole 11 extending intermediate boundary lines 41 to 47 result.
- the recesses 38 are formed corresponding to the total base area of the pillow-like layers 12 to 15.
- a cushion-like elastic intermediate layer is provided over the entire surface of the sole body.
- the intermediate layer is made of the same elastic material as the pillow-like layers 12 to 16 and firmly connected to the entire surface of one of the depressions having layers of the sole body, preferably glued.
- the pillow-like intermediate layer may have an approximately uniform thickness over the entire base surface in the range of 2 to 3 mm, so that a solid flat cushion results, which is considerably more elastic than the layers of the sole body 36 and they can only between the lower layer and the middle layer be placed over the entire surface.
- the intermediate layer between the middle layer 34 and the upper layer 33 may instead have different thickness, so that the -
- the upper layer or recesses are provided with recesses corresponding to the depressions 38 for receiving the pillow-like layers 12 to 16, in turn, on the upper material or the sole cover layer in the same manner as the sole cover layer 37 after the FIGS. 2 and 3 extends.
- the two indentations 61 and 62 which lie under the second and third metatarsal heads in use, start from the upper side of the sole cover layer 37.
- the depth of the indentations 61, 62 essentially corresponds approximately to the thickness of the two cork layers 33 and 34 or the intermediate layer, so that they extend to the bottom of the sole base body 36.
- the bottom of the indentations 61, 62 is formed by the sole cover layer 37.
- the two in the transverse direction of the shoe inner sole 11 adjacent recesses 61 and 62 are seen in the longitudinal direction of the shoe inner sole 11 in alignment with the field 19 and with the field 20 of the first pillow-like layer 12.
- the two indentations 61 and 62 substantially approximately midway between the first pillow-like layer 12 and the second pillow-like layer 13.
- the insole 111 has a two-layer sole base body 136, which forms the basic shape of the insole 111 and according to FIG. 4 according to a foot, here the left foot is formed. It goes without saying that the corresponding other, ie the right insole is formed mirror-symmetrical.
- the sole base body 136 is constructed from, for example, two cork layers or elastic plastic layers 133, 135, on which a sole cover layer 137, made of leather, is provided.
- the sole base body 136 and the sole cover layer 137 are the pillow-like layers 112 to 115 in the Layer 133 of the sole body 136 is recessed manner.
- the sole base body 136 is provided with corresponding recesses 138, which have a different base area according to the fields 118 to 127 of the pillow-like layers 112 to 114 and corresponding to the pillow-like layer 115.
- the sole body 136 has a maximum thickness in the range of 3.5 to 4 mm, preferably 3.7 mm and a minimum thickness in the region of its recesses 138 between about 1 mm and 1.5 mm, preferably of 1.3 mm.
- the example of multilayer sole sole body 136 may be coated over its entire surface of a fine textile overlay on its upper side.
- the underside of the sole body 136 may be coated over the entire surface with such a fine textile support.
- the sole base body 136 or its layers are produced from pressed with a binder cork scrap or from a plastic foam or natural latex.
- the upper side of the upper layer 133 of the sole base body 136 is also covered over its entire surface with a thin elastic intermediate layer 151, shown only as a thicker line.
- the intermediate layer 151 thus covers the entire surface, including the depressions 138 of the sole base body 136, so that recesses 152 corresponding to the depressions 138 are retained in the intermediate layer 151.
- the intermediate layer 151 has a continuous thickness of, for example, about 3 mm.
- the intermediate layer 151 is preferably like the pillow-like layers 112 to 116 of a foam, for example. Foamed natural latex.
- the pillow-like layers 112 to 115 are inserted, which are, for example, from said foamed natural latex and which, for example, have a thickness in the range between 4 and 5 mm, preferably 4.5 mm.
- the pillow-like layer 116 is for the arch of the foot not in a depression but directly on the plane in this area, ie provided without recess intermediate layer 151.
- This pillow-like layer 116 is at its thickest point also about 4 to 5 mm, preferably 4.5 mm thick, wherein it decreases towards the inside of the sole 111 out steadily in thickness.
- the flat upper sides 156 of the plateau-like pillow-like layers 112 to 115 are thus raised by 1.5 to 2.5 mm, preferably by approximately 2 mm, from the upper side 157 of the intermediate layer 151.
- the upper material or the sole cover layer 137 covers the pillow-like layer 116 and also the pillow-like layers 112 to 115 such that the latter or their panels 118 to 127 are surrounded at the edge and firmly bonded to the intermediate layer 151, preferably glued, so that except the boundary lines 128, 129 and 131, 132 approximately perpendicular to the transverse direction of the insole 111 extending intermediate boundary lines or areas 141 to 147 result.
- the inner panel 123 is arcuately pulled over the outer panel 125 and the middle panel 124.
- This arcuate advanced portion 163 extends and widens the front surface of the field 123 FIG. 5 can be seen, this arcuate preferred region 163 is not flat as the other surface areas of the pillow-like layer 113, but curved upwards as a dome, ie raised against the raised top of the sole cover layer 137 again.
- This camber 163 raises the level of the field 123 in this area with respect to the fields 124 and 125 by about 2 mm and thus even further with respect to the indentations 161 and 162.
- the dents 161 and 162 are also in this embodiment in longitudinal alignment with the second and third field 119 and 120 of the first In addition, they are located in a region between the first pillow-like layer 112 and the second pillow-like layer 113, substantially centrally between them. Furthermore, the position of the arcuate, ie arched, region is such that its tip 163 is approximately aligned with the transitional region from one indentation 161 to the other indentation 162 in the longitudinal extension of the shoe inner sole 111. In this way, due to the additional increase relative to the bottom of the indentation 161, 162, this arched region 163 of the field 123 causes a further increase in the pressure relief of the respective two metatarsal heads.
- the base of the dome 163 may be larger than the pressure gauge of the indentation 161, 162.
- adjacent discrete circular lobes, such as 61 and 62, 161 and 162 are combined into a single oval-in-plan view.
Abstract
Description
Die vorliegende Erfindung bezieht sich auf eine als Fußbett ausgebildete Schuhinnensohle nach dem Oberbegriff des Anspruchs 1.The present invention relates to a shoe sole designed as a footbed according to the preamble of claim 1.
Durchschnittlich jeder fünfte der Altersgruppe zwischen 20 und 70 Jahren ist wegen eines Venenleidens behandlungsbedürftig und gar jeder dritte hat pathologische Venenveränderungen, die zwar noch nicht invasiv behandlungsbedürftig sind, aber dennoch Beschwerden verursachen und behandlungsbedürftig werden können. Dies rührt im Allgemeinen von einer oft erblich bedingten Bindegewebsschwäche her, was zu einer Erschlaffung der Venenwände und damit zu einer mangelnden Schließfähigkeit der Venenklappen führt. Dadurch kommt es zu einer Reduktion des venösen Rückstroms aus den Beinen in den Körper. Eine Schuhinnensohle für solche Personen ist aus der
Aus der
Außerdem gibt es in Deutschland ca. 5 Millionen Diabetiker, bei denen sich ein sogenannter "diabetischer Fuß" in mehr oder weniger gravierender Form einstellen kann. Dies bedeutet: An der Fußsohle des Vorfußes offene Wunden, die sich infizieren können und die in nicht seltenen Fällen zur Notwendigkeit einer Fußamputation (pro Jahr ca. 25000 in Deutschland) führen. Die Ursachen des diabetischen Fußes liegen darin, dass es aufgrund der diabetischen Stoffwechsellage im arteriellen Gefäßsystem zur Verengung und unter Umständen zum Verschluss von größeren Arterien (Makroangiopathie) und kleineren Arterien und Kapillaren (Mikroangiopathie) kommt. Dadurch wird das Gewebe insbesondere die Haut nicht mehr ausreichend mit Sauerstoff versorgt und geht teilweise zugrunde (offene Stelle). Durch die Minderfunktion, insbesondere der arteriellen Kapillaren werden die Hautnerven nicht mehr ausreichend ernährt und es kommt zu einer diabetischen Polyneuropathie. Dies bedeutet, dass bei dem Betroffenen in dem nicht mehr ausreichend ernährten Hautgebiet die Sensibilität und damit das Schmerzempfinden deutlich nachlässt, so dass anatomisch vorgegebene Druckstellen nicht mehr registriert werden und die Haut dadurch "schmerzfrei" Schaden nimmt und es in diesem Bereich zu einer offenen Hautstelle kommt.In addition, there are approximately 5 million diabetics in Germany, where a so-called "diabetic foot" can be more or less severe. This means: At the sole of the forefoot, open wounds that can become infected and that in rare cases lead to the necessity of a foot amputation (about 25,000 in Germany per year). The causes of the diabetic foot are that due to the diabetic metabolic condition in the arterial vascular system to narrow and possibly occlude larger arteries (macroangiopathy) and smaller arteries and capillaries (microangiopathy) comes. As a result, the tissue, in particular the skin, is no longer supplied with sufficient oxygen and is partially destroyed (open area). Due to the minor function, in particular the arterial capillaries, the skin nerves are no longer sufficiently nourished and there is diabetic polyneuropathy. This means that the affected person in the skin area, which is no longer sufficiently nourished, clearly loses the sensibility and thus the sensation of pain, so that anatomically prescribed pressure points are no longer registered and the skin is damaged "painlessly" and in this area an open skin area comes.
Aufgabe der vorliegenden Erfindung ist es deshalb, eine Schuhinnensohle der eingangs genannten Art zu schaffen, die für Diabetiker geeignet ist, d.h., die bei bleibender Unterstützung des arteriellen Einstromes in den Fuß- bzw. Fußsohlenbereich eine weitergehende positive Beeinflussung der durch die diabetische Stoffwechsellage gefährdeten Fuß- bzw. Fußsohlenbereiche mit sich bringt.Object of the present invention is therefore to provide a shoe insole of the type mentioned, which is suitable for diabetics, ie, with continued support of the arterial inflow in the foot or sole area a more positive influence on endangered by the diabetic metabolic condition foot - or soles areas brings with it.
Zur Lösung dieser Aufgabe sind bei einer Schuhinnensohle der genannten Art die im Anspruch 1 angegebenen Merkmale vorgesehen.To solve this problem, the features specified in claim 1 are provided in a shoe insole of the type mentioned.
Auch wenn die gewünschten Ansatzpunkte zur Unterstützung einerseits des arteriellen Einstroms und andererseits der durch die diabetische Stoffwechsellage gefährdeten Stellen zunächst konträr erscheinen, wird durch die erfindungsgemäßen Maßnahmen erreicht, dass bei in gleichbleibender Weise verbessertem arteriellem Einstrom diejenigen an sich bekannten gefährdeten Stellen des Fußes bzw. der Fußsohle derart entlastet werden können, dass diese gefährdeten Stellen sich nicht öffnen, und darüber hinaus sogar derart, dass bereits offene Stellen über einen akzeptablen Zeitraum hinweg wieder zugehen. Im ersten Falle können Druckpunkte, die zu einem Öffnen der bestimmten Stellen führen, gar nicht entstehen, während im zweiten Falle durch die Druckentlastung der anatomisch gefährdeten Stellen diese wieder zugehen können, wobei in beiden Fällen die Verbesserung des arteriellen Einstromes und damit der Durchblutung im Kapillarbereich das Ihrige dazu beträgt. Diese Druckentlastung ergibt sich dadurch, das aufgrund der Eindellungen die Mittelfußköpfchen auf der Oberseite der Sohlenfläche nicht aufliegen sondern sozusagen frei schweben. Dabei bleiben, wie erwähnt, die diskreten Widerlagerbereiche für eine Verbesserung der venösen Rückflussgeschwindigkeit erhalten, d.h. es kommt zu einer Entlastung der peripheren Venen und venösen Kapillaren, was den arteriellen Blutzufluss erhöht und damit eine Verbesserung der Durchblutung und der Sauerstoffversorgung des Gewebes bedeutet. Durch die verbesserte kapillare arterielle Durchblutung kommt es zu einer verbesserten Versorgung der sensiblen Nerven der Hautareale; die Sensibilität und damit das Schmerzempfinden in den betroffenen Hautarealen wird verbessert und damit die Gefahr, dass diese Hautareale aufgehen, reduziert. Alle diese Komponenten helfen das Auftreten des diabetischen Fußes zu vermeiden und falls vorhanden einen diabetischen Fuß ohne Amputation zu heilen.Even if the desired starting points for the support of the arterial inflow on the one hand and on the other hand endangered by the diabetic metabolic situation initially appear contrary, is achieved by the measures according to the invention that in a consistently improved arterial inflow those known endangered areas of the foot or the The sole of the foot can be relieved to such an extent that these vulnerable areas do not open up and, in addition, even so that vacancies recur over an acceptable period of time. In the first case, pressure points that lead to an opening of the specific places, do not arise, while in the second case by the pressure relief of the anatomically vulnerable sites they can go back, in both cases, the improvement of the arterial inflow and thus the blood flow in the capillary that is yours. This pressure relief results from the fact that due to the dents the metatarsal heads do not rest on the upper side of the sole surface but, so to speak, float freely. In this case, as mentioned, the discrete abutment areas for an improvement of the venous return flow are maintained, ie it comes to a relief of the peripheral veins and venous capillaries, which increases the arterial blood flow and thus means an improvement of the blood circulation and oxygenation of the tissue. The improved capillary arterial blood circulation leads to an improved supply of the sensitive nerves of the skin areas; the sensibility and thus the sensation of pain in the affected areas of the skin is improved, thus reducing the risk that these areas of the skin will open. All these components help the appearance of the diabetic foot too avoid and, if available, heal a diabetic foot without amputation.
Mit den Merkmalen nach Anspruch 2 ist erreicht, dass insbesondere die hauptsächlich anatomisch gefährdeten Bereiche entlastet werden. Weitere Ausgestaltungen ergeben sich aus den Merkmalen nach Anspruch 3 und/oder 4. Eine vorteilhafte Anordnung der Eindellungen in Bezug auf das oder die kissenartigen Schichten ergeben sich aus den Merkmalen nach Anspruch 5.With the features of claim 2 it is achieved that in particular the mainly anatomically endangered areas are relieved. Further embodiments result from the features according to claim 3 and / or 4. An advantageous arrangement of the indentations with respect to the pillow-like layers results from the features according to claim 5.
Eine besonders vorteilhafte Ausgestaltung ergibt sich aus den Merkmalen nach Anspruch 6 und/oder in Verbindung hiermit aus den Merkmalen nach Anspruch 7 bzw. 8, da dadurch eine weitere Unterstützung des sogenannten Schwebezustandes der anatomisch gefährdeten Stellen und damit deren weiterer Druckentlastung erreicht ist.A particularly advantageous embodiment results from the features of claim 6 and / or in conjunction herewith from the features of claim 7 and 8, as a further support of the so-called floating state of the anatomically vulnerable sites and thus their further pressure relief is achieved.
Zur weiteren Unterstützung der Durchblutung sind die Merkmale nach Anspruch 9 und/oder 10 vorgesehen. Dabei können die Merkmale nach Anspruch 11 zweckmäßig sein.To further promote blood circulation, the features of claim 9 and / or 10 are provided. The features of
Mit den Merkmalen nach Anspruch 12 ist erreicht, dass die Schuhinnensohle als Individualanfertigung entsprechend den bei einem Patienten festgestellten anatomisch gefährdeten Stellen vorgesehen ist, während die Merkmale nach Anspruch 13 eher eine Seriensohlenanfertigung betreffen.With the features according to
Weitere Einzelheiten der Erfindung sind der folgenden Beschreibung zu entnehmen, in der die Erfindung anhand der in der Zeichnung dargestellten Ausführungsbeispiele näher beschrieben und erläutert ist. Es zeigen:
- Figur 1
- eine Draufsicht auf eine Schuhinnensohle gemäß einem ersten Ausführungsbeispiel vorliegender Erfindung,
- Figur 2
- in vergrößerter Darstellung einen Schnitt längs der Linie II-II der
Figur 2 , - Figur 3
- in vergrößerter Darstellung einen Schnitt längs der Linie III-III der
Figur 1 , - Figur 4
- eine Draufsicht auf eine Schuhinnensohle gemäß einem zweiten Ausführungsbeispiel vorliegender Erfindung,
- Figur 5
- einen Schnitt längs der Linie V-V der
Figur 4 und - Figur 6
- eine Innenansicht gemäß Pfeil VI der
Figur 4 .
- FIG. 1
- a top view of a shoe inner sole according to a first embodiment of the present invention,
- FIG. 2
- in an enlarged view a section along the line II-II of
FIG. 2 . - FIG. 3
- in an enlarged view a section along the line III-III of
FIG. 1 . - FIG. 4
- a plan view of a shoe inner sole according to a second embodiment of the present invention,
- FIG. 5
- a section along the line VV of
FIG. 4 and - FIG. 6
- an interior view according to arrow VI of
FIG. 4 ,
Die in der Zeichnung dargestellte und bspw. als Fußbett ausgebildete Schuhinnensohle 11 bzw. 111 gemäß zweier Ausführungsbeispiele vorliegender Erfindung dient in Kombination sowohl der synergistischen Unterstützung der Muskulatur bei der Bewegung der Fuß- und Sprunggelenke zur Verbesserung des arteriellen Einstroms in den Fuß- und Fußsohlenbereich und damit der Durchblutung in den Kapillaren als auch der mechanischen Entlastung von Problembereichen an den Fußsohlen aufgrund (schlechter) diabetischer Stoffwechsellage. Sie kann als Einlegesohle oder als in einen Schuh integrierte Sohle ausgebildet sein.The illustrated in the drawing and, for example, designed as a footbed shoe
Wie aus den
Die erste kissenartige Schicht 12, 112 ist im Vorfußgelenkbereich, d.h. im Bereich der Fußzehen vorgesehen.The first pillow-
Diese erste kissenartige Schicht 12, 112 ist in die fünf voneinander getrennten und in Querrichtung der Innensohle 11, 111 nebeneinanderliegend angeordnete Felder 18 bis 22, 118 bis 122 unterteilt. Die einzelnen Felder 18 bis 22, 118 bis 122 sind unterschiedlich breit und lang, entsprechend etwa der Grundfläche der Teilbereiche der jeweiligen einzelnen Zehen. Entsprechendes gilt für die Form der vorderen und hinteren Grenzlinie 28, 128 bzw. 29, 129 dieser ersten kissenartigen Schicht 12, 112. Die zweite kissenartige Schicht 13, 113 ist im Übergangsbereich von Mittelfuß und Fußwurzel und in einem Bereich, der dem Fußgewölbe abgewandt ist, vorgesehen. Diese zweite kissenartige Schicht 13, 113 ist in die drei Felder 23 bis 25, 123 bis 125 unterteilt, die entsprechend diesem Teilbereich von Mittelfuß/Fußwurzel geformt und in Querrichtung der Innensohle 11, 111 nebeneinander liegend unterteilt angeordnet sind. Entsprechendes gilt für die Form der Umfangsgrenzlinie 31, 131 dieser zweiten kissenartigen Schicht 13, 113. Die dritte kissenartige Schicht 14, 114 ist in einem Übergangsbereich von Mittelfuß und Ferse vorgesehen und in die beiden Felder 26, 126 und 27, 127 unterteilt, die in Querrichtung der Innensohle 11, 111 gesehen nebeneinander liegen und seitlich außen vorgesehen sind. Auch hier entspricht die Umfangsgrenzlinie 32, 132 etwa dem Übergangsbereich von Mittelfuß zur Ferse.This first cushion-
Die vierte kissenartige Schicht 15 bzw. 115 ist im Bereich der Ferse angeordnet und plateauartig als einheitliche nicht unterteilte, in Quer- bzw. Längsrichtung der Innensohle 11, 111 etwa ovaläre Schicht ausgebildet. Ebenso ist die fünfte kissenartige Schicht 16, 116 als einheitliche nicht unterteilte Schicht ausgebildet, jedoch im Bereich des Fußgewölbes etwa sichelförmig vorgesehen.The fourth pillow-
Die kissenartigen Schichten 12 bis 16, 112 bis 116 sind aus einem elastischen (Schaumstoff-)Material, bspw. einem Silikon hergestellt. Sie besitzen eine ebene obere Fläche und sind im Querschnitt etwa rechteckförmig, vorteilhaft leicht trapezförmig ausgebildet.The pillow-
Des weiteren ist bzw. sind zwischen der ersten kissenartigen Schicht 12, 112 im Vorfußgelenkbereich und der zweiten kissenartigen Schicht 13, 113 im Mittelfuß/Fußwurzel-Übergangsbereich eine oder mehrerer der Druckentlastung des oder der Mittelfußköpfchen dienende Eindellungen 61, 62 bzw. 161, 162 vorgesehen. Bei den Ausführungsbeispielen sind die Eindellungen 61, 62 bzw. 161, 162 im Bereich des zweiten und dritten Mittelfußköpfchens angeordnet; es versteht sich, dass diese stattdessen in anderer Anzahl und Kombination im Bereich des ersten, zweiten, dritten und/oder vierten Mittelfußköpfchen angeordnet sein können.Furthermore, between the first pillow-
Beim ersten Ausführungsbeispiel gemäß den
In nicht dargestellter Weise ist es möglich, zwischen dem Sohlengrundkörper und der Sohlendeckschicht eine kissenartige elastische Zwischenschicht ganzflächig über den Sohlengrundkörper vorgesehen ist. Die Zwischenschicht ist dabei aus dem selben elastischen Material wie die kissenartigen Schichten 12 bis 16 hergestellt und mit der gesamten Oberfläche einer der keine Vertiefungen aufweisenden Schichten des Sohlengrundkörpers fest verbunden, vorzugsweise verklebt. Die kissenartige Zwischenschicht kann eine über die gesamte Grundfläche etwa einheitliche Dicke im Bereich von 2 bis 3 mm besitzen, so dass sich ein durchgezogenes ebenes Kissen ergibt, das erheblich elastischer ist als die Schichten des Sohlengrundkörpers 36 und sie kann lediglich zwischen die untere Schicht und die mittlere Schicht ganzflächig gelegt sein. Die Zwischenschicht zwischen der mittleren Schicht 34 und der oberen Schicht 33 kann stattdessen unterschiedliche Dicke besitzen, so dass die -obere Schicht mit Vertiefungen und die kissenartige Zwischenschicht mit den Vertiefungen 38 entsprechenden Vertiefungen zur Aufnahme der kissenartigen Schichten 12 bis 16 versehen sind, über die wiederum das Obermaterial bzw. die Sohlendeckschicht sich in der selben Weise wie die Sohlendeckschicht 37 nach den
Die beiden Eindellungen 61 und 62, die im Gebrauch unter dem zweiten bzw. dritten Mittelfußköpfchen liegen, gehen von der Oberseite der Sohlendeckschicht 37 aus. Die Tiefe der Eindellungen 61, 62 entspricht im Wesentlichen etwa der Dicke der beiden Korkschichten 33 und 34 bzw. der Zwischenschicht, so dass sie bis zum Boden des Sohlengrundkörpers 36 reichen. Der Grund der Eindellungen 61, 62 ist durch die Sohlendeckschicht 37 gebildet. Die beiden in Querrichtung der Schuhinnensohle 11 nebeneinander liegenden Eindellungen 61 und 62 sind in Längsrichtung der Schuhinnensohle 11 gesehen in einer Flucht mit dem Feld 19 bzw. mit dem Feld 20 der ersten kissenartigen Schicht 12. Dabei befinden sich die beiden Eindellungen 61 und 62 im Wesentlichen etwa mittig zwischen der ersten kissenartigen Schicht 12 und der zweiten kissenartigen Schicht 13.The two
Beim zweiten Ausführungsbeispiel gemäß den
Zwischen dem Sohlengrundkörper 136 und der Sohlendeckschicht 137 sind die kissenartigen Schichten 112 bis 115 in in die Schicht 133 des Sohlengrundkörpers 136 eingelassener Weise angeordnet. Dazu ist der Sohlengrundkörper 136 mit entsprechenden Vertiefungen 138 versehen, die entsprechend den Feldern 118 bis 127 der kissenartigen Schichten 112 bis 114 und entsprechend der kissenartigen Schicht 115 eine unterschiedliche Grundfläche besitzen. Beispielsweise besitzt der Sohlengrundkörper 136 eine maximale Dicke im Bereich von 3,5 bis 4 mm, vorzugsweise von 3,7 mm und eine minimale Dicke im Bereich seiner Vertiefungen 138 zwischen etwa 1 mm und 1,5 mm, vorzugsweise von 1,3 mm. Der bspw. mehrschichtige Sohlengrundkörper 136 kann an seiner Oberseite ganzflächig von einer feinen Textilauflage überzogen sein. In nicht dargestellter Weise kann statt dessen oder zusätzlich die Unterseite des Sohlengrundkörpers 136 mit einer derartigen feinen Textilauflage ganzflächig überzogen sein. Der Sohlengrundkörper 136 bzw. dessen Schichten sind aus mit einem Bindemittel gepresstem Korkschrott oder aus einem Kunststoffschaum bzw. Naturlatex hergestellt.Between the
Gemäß
In die Vertiefungen 152 der Zwischenschicht 151 sind die kissenartigen Schichten 112 bis 115 eingelegt, die bspw. aus dem genannten geschäumten Naturlatex sind und die bspw. eine Dicke im Bereich zwischen 4 und 5 mm, vorzugsweise von 4,5 mm besitzen. Demgegenüber ist die kissenartige Schicht 116 für das Fußgewölbe nicht in einer Vertiefung sondern unmittelbar auf der in diesem Bereich ebenen, d.h. ohne Vertiefung versehenen Zwischenschicht 151 angeordnet. Diese kissenartige Schicht 116 ist an ihrer dicksten Stelle ebenfalls etwa 4 bis 5 mm, vorzugsweise 4,5 mm dick, wobei sie zur Innenseite der Sohle 111 hin stetig in ihrer Dicke abnimmt. Die ebenen Oberseiten 156 der plateauartigen kissenartigen Schichten 112 bis 115 sind somit gegenüber der Oberseite 157 der Zwischenschicht 151 um 1,5 bis 2,5 mm, vorzugsweise um etwa 2 mm erhaben. Das Obermaterial bzw. die Sohlendeckschicht 137 überdeckt die kissenartige Schicht 116 und ferner die kissenartigen Schichten 112 bis 115 derart, dass die letzteren bzw. deren Felder 118 bis 127 randseitig vertieft umgeben und mit der Zwischenschicht 151 fest verbunden, vorzugsweise verklebt sind, so dass sich außer den Grenzlinien 128, 129 und 131, 132 etwa senkrecht zur Querrichtung der Innensohle 111 verlaufende Zwischengrenzlinien bzw. -bereiche 141 bis 147 ergeben.In the
Des weiteren ist bei der zweiten kissenartigen Schicht 113 gegenüber dem äußeren Feld 125 und dem mittleren Feld 124 das innere Feld 123 bogenförmig vorgezogen. Dieser bogenförmig vorgezogene Bereich 163 verlängert und verbreitert die vordere Fläche des Feldes 123. Wie der
Die Eindellungen 161 und 162 sind auch bei diesem Ausführungsbeispiel in längsgerichteter Flucht mit dem zweiten bzw. dritten Feld 119 bzw. 120 der ersten kissenartigen Schicht 112. Außerdem befinden sie sich in einem Bereich zwischen der ersten kissenartigen Schicht 112 und der zweiten kissenartigen Schicht 113, und zwar im Wesentlichen mittig zwischen diesen. Des weiteren ist die Lage des bogenförmig vorgezogenen, d.h. gewölbten Bereichs derart, dass sich dessen Kuppe 163 in längsgerichteter Erstreckung der Schuhinnensohle 111 etwa in Flucht mit dem Übergangsbereich von der einen Eindellung 161 zur anderen Eindellung 162 befindet. Auf diese Weise bewirkt dieser gewölbte Bereich 163 des Feldes 123 aufgrund der zusätzlichen Erhöhung gegenüber dem Grund der Eindellung 161, 162 eine weitere Erhöhung der Druckentlastung der betreffenden beiden Mittelfußköpfchen. Auch bei diesem Ausführungsbeispiel befindet sich der Grund der Eindellungen 161, 162 nahe dem Boden des Sohlengrundkörpers 136, wobei die kreisförmige Grundfläche etwa der anatomischen Flächengestaltung des betreffenden Mittelfußköpfchens entspricht Die Grundfläche der Kuppe 163 kann größer als der Druckmesser der Eindellung 161, 162 sein. Bei einer nicht dargestellten Ausführungsform sind benachbarte diskrete kreisförmige Eindellungen, wie 61 und 62 bzw. 161 und 162, zu einer einzigen in Draufsicht ovalen Eindellung vereinigt.The
Claims (13)
- A shoe insole (11, 111) for diabetics, having a sole base body (36, 136'), having a sole covering layer (37, 137), and having a plurality of cushion-like layers (12, 13, 14, 15, 16, 112, 113, 114, 115, 116), provided over the surface of the sole, in the form of at least one first cushion-like layer (12, 112) in the forefoot joint area, a second cushion-like layer (13, 113) in the midfoot/tarsus transition area, and a third cushion-like layer (14, 114) in the midfoot/heel transition area, these cushion-like layers, serving to assist the venous blood draining, are each individually divided into individual plateau-like areas (18 through 27, 118 through 127), located adjacent one another in the transversal direction of the sole surface (17, 117) and separated from one another, and the top side of the cushion-like layers, likewise covered by the sole covering layer (37, 137), forms an approximate plane with the top side of the sole base body (36) or is raised relative to the plane of the top of the sole base body (136), characterized in that between the first cushion-like layer (12, 112) in the forefoot joint area and the second cushion- like layer (13, 113) in the midfoot/tarsus transition area, discrete depressions (61, 62; 161, 162) are provided, serving to relieve the pressure on the heads of the corresponding metatarsal bones and originating at the top side of the sole base body (36, 136).
- The shoe insole of claim 1, characterized in that one depression (61; 161) is provided for the second head of he metatarsal bone, and/or one depression (62, 162) is provided for the third head of the metatarsal bone.
- The shoe insole of claim 1 or 2, characterized in that one depression is provided for the first head of the metatarsal bone.
- The shoe insole of at least one of claims 1 through 3, characterized in that one depression is provided for the fourth head of the metatarsal bone.
- The shoe insole of at least one of claims 2 through 4, characterized in that the depression (61, 62; 161, 162) for the respective head of the metatarsal bone is located approximately in alignment with the respectively associated plateau-like area (18 through 21, 118 through 121) of the first cushion-like layer (12, 112).
- The shoe insole, in which the second cushion-like layer (113) is provided with an inner field area (123), drawn forward in a curve toward the first cushion-like layer (112) and arched so as to protrude relative to the raised top side of the sole covering layer (137) of the other areas or fields of the second cushion-like layer (113), of claim 1 or 2, characterized in that the drawn-forward inner field area (163) protruding in dome fashion, is in alignment with the portions adjoining one another of the two depressions (161, 162) for the second and third heads of the metatarsal bones.
- The shoe insole of claim 6, characterized in that the diameter of the drawn-forward and protruding inner field area (163) is greater than the diameter of the depression (161, 162) for the second and for the third head of the metatarsal bone, respectively.
- The shoe insole of claim 6 or 7, characterized in that the arching of the area (123) drawn forward in a curve raises the level by approximately 2 mm.
- The shoe insole of at least one of the foregoing claims, characterized in that in the region of the heel, a fourth cushion-like layer (15, 115) is provided, which is plateau-like and preferably homogeneously oval in the transversal direction of the sole.
- The shoe insole of at least one of the foregoing claims, characterized in that in the region of the plantar arch, a fifth cushion-like layer (16, 116) is provided of crescent-like shape.
- The shoe insole of at least one of the foregoing claims, characterized in that the cushion-like layers (13 through 16; 113 through 116) are formed by a soft foam.
- The shoe insole of at least one of claims 1 through 11, characterized in that it is embodied as a replaceable separately inserted insole.
- The shoe insole of at least one of claims 1 through 11, characterized in that it is embodied as a sole that is integrated with a shoe.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10218987A DE10218987A1 (en) | 2002-04-24 | 2002-04-24 | Shoe insole for diabetics |
DE10218987 | 2002-04-24 | ||
PCT/EP2003/003705 WO2003090573A1 (en) | 2002-04-24 | 2003-04-10 | Shoe insole for diabetics |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1496764A1 EP1496764A1 (en) | 2005-01-19 |
EP1496764B1 true EP1496764B1 (en) | 2009-09-23 |
Family
ID=28798876
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP03724991A Expired - Lifetime EP1496764B1 (en) | 2002-04-24 | 2003-04-10 | Shoe insole for diabetics |
Country Status (7)
Country | Link |
---|---|
US (1) | US7380352B2 (en) |
EP (1) | EP1496764B1 (en) |
JP (1) | JP2005527282A (en) |
AT (1) | ATE443459T1 (en) |
AU (1) | AU2003227590A1 (en) |
DE (2) | DE10218987A1 (en) |
WO (1) | WO2003090573A1 (en) |
Families Citing this family (71)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040211086A1 (en) * | 2003-04-23 | 2004-10-28 | Hbn Shoe, Llc | Device for high-heeled shoes |
WO2005025356A2 (en) | 2003-09-16 | 2005-03-24 | Yehoshua Barak | Orthopedic insoles for protecting skin from stretching and cracking in the area of the five metatarsal heads of the forefoot |
US7020990B2 (en) * | 2004-01-13 | 2006-04-04 | M. Steven Khoury | Orthopedic device for distributing pressure |
JP2008505688A (en) * | 2004-07-10 | 2008-02-28 | ジ−ウグ キム | Human body correction method and apparatus |
US20060230643A1 (en) * | 2005-03-23 | 2006-10-19 | Michael Affleck | Footwear with additional comfort |
DE102005015863A1 (en) * | 2005-04-07 | 2006-10-12 | Stumpf, Jürgen | footbed |
DE102007030477A1 (en) | 2007-06-28 | 2009-01-02 | Thomas Beuke | Pressure-sensitive problem area discharging control device for use at foot region of diabetic diseased person, has offset chamber into which pressure is returned, and fluid is returning into discharging chamber |
JP5211275B2 (en) * | 2007-07-10 | 2013-06-12 | 株式会社オステオ | Footwear insoles and footwear |
US8166672B2 (en) * | 2007-09-06 | 2012-05-01 | New Balance Athletic Shoe, Inc. | Shoe sole and shoe for midfoot striker |
GB2454179A (en) * | 2007-10-30 | 2009-05-06 | Italvision Company Ltd | Insole |
JP5438023B2 (en) * | 2007-11-21 | 2014-03-12 | スペンコ、メディカル、コーパレイシャン | Insole for arthritis and diabetes |
EP2259759A4 (en) * | 2008-03-31 | 2017-08-02 | Guardaheel IP Pty Limited | Lower limb orthosis |
US8117769B2 (en) * | 2008-09-25 | 2012-02-21 | Munro & Company, Inc. | Cushioned shoe construction including toe and heel plates |
US20120023776A1 (en) * | 2009-03-09 | 2012-02-02 | Aetrex Worldwide, Inc. | Shoe sole inserts for pressure distribution |
CZ305533B6 (en) * | 2009-04-08 | 2015-11-25 | UPMAN s.r.o. | Optimized insole structure of footwear for diabetics |
KR100933527B1 (en) * | 2009-06-04 | 2009-12-23 | 주식회사 트렉스타 | Insole of footwear |
US9055781B2 (en) * | 2009-10-08 | 2015-06-16 | Varithotics Co., Ltd. | Body balance device |
FR2953395B1 (en) | 2009-12-09 | 2012-01-27 | Pascal Chenut | ORTHOPEDIC SOLE COMPRISING CORRECTION MEANS FOR THE TREATMENT OF METATARSALGIA AND PLANT CUTANEOUS DISEASES |
US20110162234A1 (en) * | 2010-01-05 | 2011-07-07 | Norman Dean | Shoe insole with flexible inserts |
US20110192050A1 (en) * | 2010-02-10 | 2011-08-11 | Jorge Hane | Insole for Shoe |
AU2011270871B2 (en) | 2010-06-25 | 2014-10-09 | Implus Footcare, Llc | Contoured support insole |
US8800168B1 (en) * | 2011-06-15 | 2014-08-12 | Robert Propét | Customizable insole |
US9215908B1 (en) * | 2011-12-13 | 2015-12-22 | Otz Shoes, Inc. | Foot bed |
DE102013214057A1 (en) | 2013-07-17 | 2015-01-22 | Oped Ag | Orthopedic shoe insole to avoid excessive pressure |
DE202013103808U1 (en) | 2013-08-22 | 2013-11-15 | Christian Lenthe | Forefoot cushion, computer program product for custom fabrication of the forefoot cushion |
US9380828B2 (en) * | 2013-12-13 | 2016-07-05 | Po-Yao Lee | Structure of athletic shoe |
US20170027277A1 (en) * | 2014-01-21 | 2017-02-02 | Implus Footcare, Llc | Customizable Component Insole System |
USD738083S1 (en) * | 2014-10-20 | 2015-09-08 | Denise A. Kojak | Replaceable arch-supportive sandal insole |
US10244818B2 (en) | 2015-02-18 | 2019-04-02 | Clemson University Research Foundation | Variable hardness orthotic |
WO2016191505A1 (en) | 2015-05-28 | 2016-12-01 | Spenco Medical Corporation | Contoured support shoe insole |
JP2018516118A (en) | 2015-05-28 | 2018-06-21 | インプラス フットケア、エルエルシー | Contour support insoles |
JP2018515205A (en) | 2015-05-28 | 2018-06-14 | インプラス フットケア、エルエルシー | Insoles |
JP2018515173A (en) | 2015-05-28 | 2018-06-14 | インプラス フットケア、エルエルシー | Shoe insole with curved support |
USD761543S1 (en) | 2015-06-25 | 2016-07-19 | Spenco Medical Corporation | Shoe insole |
USD771921S1 (en) | 2015-06-25 | 2016-11-22 | Implus Footcare, Llc | Shoe insole |
USD762367S1 (en) | 2015-06-25 | 2016-08-02 | Spenco Medical Corporation | Shoe insole |
USD762366S1 (en) | 2015-06-25 | 2016-08-02 | Spenco Medical Corporation | Shoe insole |
USD762368S1 (en) | 2015-06-25 | 2016-08-02 | Spenco Medical Corporation | Shoe insole |
USD766560S1 (en) | 2015-06-25 | 2016-09-20 | Implus Footcare, Llc | Shoe insole |
USD758058S1 (en) | 2015-06-25 | 2016-06-07 | Spenco Medical Corporation | Heel cup |
USD797428S1 (en) | 2015-07-15 | 2017-09-19 | Implus Footcare, Llc | Shoe insole |
USD797430S1 (en) | 2015-07-15 | 2017-09-19 | Implus Footcare, Llc | Shoe insole |
USD797429S1 (en) | 2015-07-15 | 2017-09-19 | Implus Footcare, Llc | Shoe insole |
USD771922S1 (en) | 2015-09-15 | 2016-11-22 | Implus Footcare, Llc | Shoe insole |
USD778567S1 (en) | 2015-09-17 | 2017-02-14 | Implus Footcare, Llc | Shoe insole |
USD778040S1 (en) | 2015-09-25 | 2017-02-07 | Implus Footcare, Llc | Shoe insole |
USD814750S1 (en) | 2015-09-25 | 2018-04-10 | Fourfoot, Llc | Sandal |
US10856610B2 (en) | 2016-01-15 | 2020-12-08 | Hoe-Phuan Ng | Manual and dynamic shoe comfortness adjustment methods |
USD833726S1 (en) * | 2016-02-05 | 2018-11-20 | Shinen Biotechnology Co., Ltd. | Shoe insole |
US10390587B2 (en) * | 2016-03-01 | 2019-08-27 | Hbn Shoe, Llc | Device for high-heeled shoes and method of constructing a high-heeled shoe |
US10477915B2 (en) | 2016-03-01 | 2019-11-19 | Hbn Shoe, Llc | Device for high-heeled shoes and method of constructing a high-heeled shoe |
JP6117964B1 (en) * | 2016-03-25 | 2017-04-19 | 美津濃株式会社 | Sole structure for shoes and shoes using the same |
ITUA20162683A1 (en) * | 2016-04-18 | 2017-10-18 | Tecnica Group Spa | Insole for footwear |
USD796175S1 (en) * | 2016-05-11 | 2017-09-05 | Vionic Group LLC | Shoe midsole |
ITUA20163527A1 (en) * | 2016-05-19 | 2017-11-19 | Basket1 Srls | Insole for podalic support and ambulatory assistance |
US10441028B2 (en) * | 2016-06-20 | 2019-10-15 | Fuerst Group, Inc. | Variable-density soles for articles of footwear |
CN206964142U (en) * | 2016-07-01 | 2018-02-06 | 玛尔塔·埃斯特拉达·维卡洛斯 | The plan body formula inner sole of footwear |
US20180014603A1 (en) * | 2016-07-12 | 2018-01-18 | Antonia Saint Dunbar | Footware system |
EP3509544B1 (en) * | 2016-09-06 | 2021-12-15 | Kinetic Orthotics Pty Ltd | An orthotic product |
GB2555084B (en) * | 2016-10-07 | 2019-12-04 | Fitflop Ltd | An item of footwear |
CN106626350A (en) * | 2016-12-09 | 2017-05-10 | 陕西科技大学 | Pressure reduction and protection insoles applying to high-risk diabetic foot groups and manufacturing method thereof |
US10702008B2 (en) * | 2018-02-26 | 2020-07-07 | Hbn Shoe, Llc | Device and method of constructing shoes |
US11033070B2 (en) * | 2018-03-29 | 2021-06-15 | Maryam Raza | Device for preventing and treating foot and leg ulcers |
USD866141S1 (en) * | 2019-01-10 | 2019-11-12 | Nike, Inc. | Shoe |
WO2021024341A1 (en) * | 2019-08-05 | 2021-02-11 | Nasyu株式会社 | Shoe insole |
US11412815B1 (en) | 2020-01-21 | 2022-08-16 | Kathrine Sereg-Mangano | Foot therapy system |
US11864626B2 (en) * | 2020-10-12 | 2024-01-09 | William Gilmore | Method and device for preventing sprained ankles |
CN113303550B (en) * | 2021-06-04 | 2023-04-07 | 贵阳市第四人民医院 | Diabetic foot shoe for phalangeal joint fusion patient and preparation method thereof |
US11540588B1 (en) | 2021-11-24 | 2023-01-03 | Hbn Shoe, Llc | Footwear insole |
FR3140263A1 (en) | 2022-10-01 | 2024-04-05 | Millet Innovation | Plantar pump stimulation device for improving venous return |
US11805850B1 (en) * | 2023-07-19 | 2023-11-07 | Hbn Shoe, Llc | Cuboid pad |
Family Cites Families (48)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US492994A (en) * | 1893-03-07 | Inner sole | ||
US2734287A (en) * | 1956-02-14 | Maccarone | ||
US1093608A (en) * | 1913-05-05 | 1914-04-21 | Bernard Delaney | Arch and heel support and insole. |
US1730466A (en) * | 1926-12-31 | 1929-10-08 | Joseph A Mallott | Insole |
US1841942A (en) * | 1929-04-11 | 1932-01-19 | Fenton John | Cushioned insole |
BE408053A (en) * | 1930-01-04 | |||
US1867431A (en) * | 1931-03-20 | 1932-07-12 | Joseph H Wood | Cushion support |
US1907136A (en) * | 1931-08-10 | 1933-05-02 | Weitsen Albert | Metatarsal pad |
US2404731A (en) * | 1943-11-29 | 1946-07-23 | Ross H Johnson | Making insoles |
US2423622A (en) * | 1945-10-02 | 1947-07-08 | Herman L Samblanet | Sesamoid-cuboid foot balancer |
US2502774A (en) * | 1948-12-20 | 1950-04-04 | Alianiello Nicholas | Cushioned shoe |
US3922801A (en) * | 1973-07-16 | 1975-12-02 | Patrick Thomas Zente | Liquid filled orthopedic apparatus |
US4020570A (en) * | 1975-10-10 | 1977-05-03 | Hiraoka New York, Inc. | Cushioned insole for footwear such as shoes, boots, or the like |
US4079526A (en) * | 1975-12-27 | 1978-03-21 | Tatsuo Fukuoka | Footwear |
US4408402A (en) * | 1982-08-05 | 1983-10-11 | Looney Judy A | Supportive shoe and insert |
DE3306425C2 (en) | 1983-02-24 | 1995-03-09 | Designstart Ltd | Upholstery stamping |
US4694831A (en) * | 1984-01-04 | 1987-09-22 | Seltzer Charles J | Massage footwear |
US4633877A (en) * | 1984-08-07 | 1987-01-06 | Duramet Systems, Inc. | Dynamic foot support and kit therefor |
JPS6140904U (en) * | 1984-08-20 | 1986-03-15 | 株式会社アサヒコーポレーション | shoe insole |
DE8431831U1 (en) | 1984-10-30 | 1985-02-07 | Orthotech Beratungs- und Vertriebsgesellschaft mbH für orthopädietechnischen Bedarf, 8035 Gauting | Footbed for inserting into shoes, in particular into sports shoes |
DE3508582A1 (en) | 1985-03-11 | 1986-09-18 | Walter Dr.med. 4000 Düsseldorf Mauch | Insert sole |
DE3527938A1 (en) * | 1985-08-03 | 1987-02-12 | Paul Ganter | SHOE OR OUTSOLE |
GB8609998D0 (en) * | 1986-04-24 | 1986-05-29 | Andrews A C | Insoles for footwear |
US4760655A (en) * | 1986-07-07 | 1988-08-02 | Walter Mauch | Insole |
DE8700681U1 (en) | 1987-01-15 | 1987-03-05 | Kuehnreich, Heinz-Peter, 5210 Troisdorf, De | |
IT1229593B (en) * | 1987-11-09 | 1991-09-04 | Luciano Geri | FOOT SUPPORT TO MAKE VARIABLE AND SELF-ADAPTABLE INDIVIDUAL CORRECTIONS FOR ORTHOPEDIC AND PREVENTION PURPOSES |
US5784811A (en) * | 1990-03-15 | 1998-07-28 | Walter Mauch | Shoe insole |
DE9002962U1 (en) | 1990-03-15 | 1990-05-17 | Mauch, Walter, Dr.Med., 4000 Duesseldorf, De | |
DE9013727U1 (en) * | 1990-10-02 | 1990-12-06 | Erbacher Ski- Und Tennis Ag, 7904 Erbach, De | |
US5179792A (en) * | 1991-04-05 | 1993-01-19 | Brantingham Charles R | Shoe sole with randomly varying support pattern |
US5167999A (en) * | 1991-06-18 | 1992-12-01 | Wang Sui Mu | Liquid cushioning means |
JPH0654702A (en) * | 1992-08-05 | 1994-03-01 | Koichi Saga | Insole subsequently inserted for shoes |
US5329705A (en) * | 1993-02-16 | 1994-07-19 | Royce Medical Company | Footgear with pressure relief zones |
AU6676694A (en) | 1993-04-15 | 1994-11-08 | Henning Raun Schoesler | Fluid filled insole |
JP2756903B2 (en) * | 1993-09-17 | 1998-05-25 | 小林製薬株式会社 | Flexible insoles |
GB9410492D0 (en) | 1994-05-25 | 1994-07-13 | Designstart Ltd | Production method |
US5509218A (en) * | 1994-12-19 | 1996-04-23 | Arcan; Mircea | Cushioning devices for feet |
DK172114B1 (en) * | 1995-07-14 | 1997-11-17 | Soeren Vindriis | Insole containing liquid |
DE19603755A1 (en) * | 1996-02-02 | 1997-08-07 | Hans Dr Med Seiter | Padded shoe inner sole |
US5768803A (en) * | 1996-05-15 | 1998-06-23 | Levy; Dodd M. | Adjustable insole for support of painful foot areas |
US5787608A (en) * | 1996-07-30 | 1998-08-04 | Greenawalt; Kent S. | Custom-made footwear |
PT971606E (en) * | 1997-05-14 | 2002-04-29 | Hans Seiter | PICKUP FOR CALCULATION |
JP4150864B2 (en) * | 1997-10-01 | 2008-09-17 | 小林製薬株式会社 | Insole for footwear |
JP4080044B2 (en) * | 1997-12-24 | 2008-04-23 | 中村ブレイス株式会社 | Plantar plate for prevention of diabetic foot lesions |
US6000147A (en) * | 1998-07-17 | 1999-12-14 | Kellerman | Three section orthotic device |
JP3462092B2 (en) * | 1998-09-24 | 2003-11-05 | バレリアンシューズ株式会社 | Shoe insole structure |
JP2000354503A (en) * | 1999-06-15 | 2000-12-26 | Kihara Sangyo Kk | Shoe insole sock for shoe |
JP3874982B2 (en) * | 2000-01-28 | 2007-01-31 | 株式会社アサヒコーポレーション | Shoe sole |
-
2002
- 2002-04-24 DE DE10218987A patent/DE10218987A1/en not_active Withdrawn
-
2003
- 2003-04-10 WO PCT/EP2003/003705 patent/WO2003090573A1/en active Application Filing
- 2003-04-10 EP EP03724991A patent/EP1496764B1/en not_active Expired - Lifetime
- 2003-04-10 US US10/511,435 patent/US7380352B2/en not_active Expired - Fee Related
- 2003-04-10 AT AT03724991T patent/ATE443459T1/en active
- 2003-04-10 AU AU2003227590A patent/AU2003227590A1/en not_active Abandoned
- 2003-04-10 DE DE50311946T patent/DE50311946D1/en not_active Expired - Lifetime
- 2003-04-10 JP JP2003587222A patent/JP2005527282A/en active Pending
Also Published As
Publication number | Publication date |
---|---|
DE50311946D1 (en) | 2009-11-05 |
US7380352B2 (en) | 2008-06-03 |
EP1496764A1 (en) | 2005-01-19 |
US20050166425A1 (en) | 2005-08-04 |
WO2003090573A1 (en) | 2003-11-06 |
ATE443459T1 (en) | 2009-10-15 |
AU2003227590A1 (en) | 2003-11-10 |
DE10218987A1 (en) | 2003-11-06 |
JP2005527282A (en) | 2005-09-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1496764B1 (en) | Shoe insole for diabetics | |
EP0971606B1 (en) | Inner sole for a shoe | |
EP0558897A1 (en) | Insole | |
DE4017224A1 (en) | FOOTWEAR WITH INSERT PILLOW | |
EP0458174A1 (en) | Footwear with sole comprising at least two layers | |
DE3152011A1 (en) | SHOE WITH INSOLE | |
WO2015185483A1 (en) | Shoe, in particular a running shoe | |
DE202007008016U1 (en) | Shoe`s insert, has heel area on which heel of foot of user lies during intended usage of insert, and longitudinal arched area on which longitudinal arch of foot of user lies during intended usage of insert | |
EP1820414A1 (en) | Insole and orthopaedic shoe therefor | |
EP2592958B1 (en) | Shoe | |
DE1000716B (en) | Foot pad for footwear with individual zones with different degrees of hardness with regard to flexibility | |
DE3227505A1 (en) | Medical therapeutic inlay sole with incorporated permanent magnets | |
DE19801301A1 (en) | Shoe insole | |
EP3609360A1 (en) | Footbed for shoes | |
DE3741444A1 (en) | Sole for footwear | |
DE19603755A1 (en) | Padded shoe inner sole | |
DE1913755C3 (en) | Footbed | |
DE895045C (en) | Orthopedic insole for footwear | |
EP3158886B1 (en) | Shoe insert with main body and core body | |
DE102012020526A1 (en) | Ballast for shoe, has two layers provided on upper sole of shoe, mold parts turned toward running shoe of shoe, and pelotte arranged under upper sole and made from polyurethane, cork, latex, silicone or ethylene-vinyl acetate | |
DE3232019A1 (en) | Shoe with shaped insert | |
DE102010022329B4 (en) | Insole and shoe | |
DE202015104193U1 (en) | Orthopedic shoe sole and shoe comprising such | |
DE102015101373B4 (en) | Functional unit for a shoe, a shoe insert or a sock | |
DE102013214057A1 (en) | Orthopedic shoe insole to avoid excessive pressure |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20040928 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR |
|
AX | Request for extension of the european patent |
Extension state: AL LT LV MK |
|
17Q | First examination report despatched |
Effective date: 20060620 |
|
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
GRAS | Grant fee paid |
Free format text: ORIGINAL CODE: EPIDOSNIGR3 |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: FG4D Free format text: NOT ENGLISH |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: EP Ref country code: CH Ref legal event code: NV Representative=s name: TROESCH SCHEIDEGGER WERNER AG |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: FG4D |
|
REF | Corresponds to: |
Ref document number: 50311946 Country of ref document: DE Date of ref document: 20091105 Kind code of ref document: P |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: FI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20090923 Ref country code: SE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20090923 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20090923 |
|
NLV1 | Nl: lapsed or annulled due to failure to fulfill the requirements of art. 29p and 29m of the patents act | ||
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: CY Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20090923 |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: FD4D |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: EE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20090923 Ref country code: PT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20100125 Ref country code: ES Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20100103 Ref country code: IE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20090923 Ref country code: RO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20090923 Ref country code: CZ Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20090923 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20090923 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: DK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20090923 Ref country code: NL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20090923 |
|
PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
26N | No opposition filed |
Effective date: 20100624 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20091224 |
|
BERE | Be: lapsed |
Owner name: SEITER, HANS Effective date: 20100430 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MC Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20100430 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: BE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20100430 Ref country code: IT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20090923 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20100410 Ref country code: HU Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20100324 Ref country code: BG Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20090923 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: TR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20090923 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 14 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: DE Payment date: 20160622 Year of fee payment: 14 Ref country code: CH Payment date: 20160422 Year of fee payment: 14 Ref country code: GB Payment date: 20160412 Year of fee payment: 14 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: AT Payment date: 20160420 Year of fee payment: 14 Ref country code: FR Payment date: 20160422 Year of fee payment: 14 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R119 Ref document number: 50311946 Country of ref document: DE |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: MM01 Ref document number: 443459 Country of ref document: AT Kind code of ref document: T Effective date: 20170410 |
|
GBPC | Gb: european patent ceased through non-payment of renewal fee |
Effective date: 20170410 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: ST Effective date: 20171229 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: FR Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20170502 Ref country code: DE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20171103 Ref country code: AT Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20170410 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: GB Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20170410 Ref country code: LI Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20170430 Ref country code: CH Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20170430 |